Moximed develops and manufactures implantable devices for knee osteoarthritis treatment. The company focuses on providing outpatient treatment options that aim to improve quality of life for patients with knee pain who are not yet candidates for knee replacement surgery.

Moximed

Runway Growth Capital

New Enterprise Associates

GBS Ventures

Vertex Ventures

Morgenthaler Ventures

Advent Life Sciences

Future Fund

Gilde Healthcare

Ischyros New York

#NEWS: We’ve secured #SeriesD financing for $91 million: https://lnkd.in/eYh3WgxQ 

Funds will be used to accelerate U.S. commercialization of the MISHA® Knee System. 
 
We’re grateful for the support from lead investor Elevage Medical Technologies, new investors Cormorant Asset Management, LP, Warren Point Capital, and existing investors New Enterprise Associates (NEA), Future Fund, Advent Life Sciences, Glide Healthcare, Vertex Ventures HC, GBS Venture Partners, and Morgenthaler.
 
#Financing #MedTech #MoveToMISHA #KneeOA #Orthopedics #SportsMedicine

Join us in congratulating Dr. Alexander Golant of NYU Langone Health on making the #MoveToMISHA! 👏
 
“The MISHA® Knee System is an excellent option for the right patient,” he said. “It just makes sense in so many ways – avoidance of premature arthroplasty, simple recovery process, and potential for significant pain relief and improvement in function, even with moderate and high-intensity activities. I am excited to have this new instrument in my surgical toolbox.”
 
#MovedToMISHA #Orthopedics #SportsMedicine #KneeOA

We are still buzzing from an exciting #AOSSM2024 last week! 

• Thursday morning Dr. Andreas Gomoll and Dr. David Diduch led a jampacked cadaver lab demonstration

• Thursday evening Dr. Sabrina Strickland and Dr. Cassandra Lee led an exceptional dinner program with The FORUM, a national group of female Orthopedic Surgeons

• Friday morning Dr. Alexander K. Meininger, M.D. FAAOS and his patient, Joe (7-months post-op), led the Moximed team on a leisurely 4-mile run through Denver, and both of them were interviewed by the Denver NBC affiliate KUSA-TV, 9NEWS 

• Friday morning Dr. jason dragoo, Dr. Seth L. Sherman and Dr. David Diduch shared their knowledge and expertise during a presentation in the exhibit hall

We sincerely appreciate the support of the American Orthopaedic Society for Sports Medicine and all of the early adopters who helped educate surgeons interested in treating patients with medial #KneeOA with an implantable shock absorber. 

#MOVEtoMISHA

Christopher Kaeding Eric McCarty Peter A Indelicato MD Moximed OLC Education and Conference Center

“Every new medical technology begins with innovators who dare to challenge the status quo, and this spirit of moxie is something I will continue to push for in this role.”
 
Christopher Gleason, new President and CEO of Moximed, shares his thoughts as this new chapter begins. Check out his article below. 👇
 
#SportsMedicine #Orthopedics #MoveToMISHA #Leadership #MedTech

https://lnkd.in/eQPa97aa

Dr. Seth L. Sherman of Stanford Health Care is among the first surgeons in the country who #MovedToMISHA! 🙌 
 
“The MISHA® Knee System is a game changer for my ‘tweener’ population with medial knee osteoarthritis - too young and active for joint replacement, but poor candidates for other joint preservation strategies. I am excited to offer this generational technology to many more patients over time.”
 
Learn more about MISHA: https://moximed.com/misha/
 
#MoveToMISHA #KneeOA #Orthopedics #SportsMedicine

Congratulations to Justin Saliman, MD on joining the first group of surgeons in the country who #MovedToMISHA! 👏 
 
“We must set our sights beyond temporary fixes. The true aim lies not in merely pushing problems ahead but in safeguarding the very joints that carry us forward. With the MISHA® Knee System, my OA patients are not just able to preserve their knee joint, but they’re able to quickly get back to the activities they love.”
 
Find out more about MISHA: https://moximed.com/misha/
 
#MoveToMISHA #KneeOA #Orthopedics #SportsMedicine

msh id	COM:MOXIMED
symbol	-
name	Moximed
homepage url	https://moximed.com
country	US
sector	Healthcare & Health Services
industry	Medical Devices
market	PRIVATE
employee count	51
crunchbase url	-
linkedin url	https://www.linkedin.com/company/moximed
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

COM:MOXIMED

Moximed

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-